PRESS RELEASE published on 05/21/2024 at 22:15, 1 year 10 months ago Nanobiotix annonce des avancees de la collaboration globale de developpement autour de NBTXR3 refletant son pipeline robuste et son approche de croissance sur le long terme Nanobiotix annonce des avancées de la collaboration globale de développement autour de NBTXR3 reflétant son pipeline robuste et son approche de croissance sur le long terme Croissance À Long Terme NANOBIOTIX NBTXR3 Collaboration Globale Pipeline Robuste
BRIEF published on 05/14/2024 at 22:20, 1 year 10 months ago NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
BRIEF published on 05/14/2024 at 22:20, 1 year 10 months ago NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
PRESS RELEASE published on 05/14/2024 at 22:15, 1 year 10 months ago NANOBIOTIX annonce l'acceptation par l'Agence américaine du médicament, la FDA, d'un protocole pour une nouvelle étude randomisée de Phase 2 évaluant NBTXR3 pour les patients atteints d'un cancer du poumon de stade trois Nanobiotix annonce l'acceptation par la FDA d'un protocole pour une nouvelle étude de phase 2 sur NBTXR3 pour le cancer du poumon de stade III FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
PRESS RELEASE published on 05/14/2024 at 22:15, 1 year 10 months ago NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer Nanobiotix announces US FDA protocol acceptance for new randomized Phase 2 study on NBTXR3 for stage three lung cancer patients Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer FDA Protocol
Published on 03/27/2026 at 15:35, 5 hours 5 minutes ago SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 8 hours 10 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 8 hours 40 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 9 hours 40 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 20:08, 32 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 1 hour 10 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:30, 1 hour 10 minutes ago FONDAZIONE MAIRE PRESENTED IN BERLIN THE "CLIMATE GOALS" STUDY IN THE FRAMEWORK OF MAIRE EUROPEAN STRATEGY LEVERAGING ON GERMANY
Published on 03/27/2026 at 19:25, 1 hour 15 minutes ago Boris Becker's 1989 U.S. Open Champion Trophy Up For Auction, $350,000+ Expected
Published on 03/27/2026 at 18:25, 2 hours 15 minutes ago Thieves Make a Break For It as 12 Tonnes of KITKAT Go Missing
Published on 03/27/2026 at 19:06, 1 hour 34 minutes ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 1 hour 48 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 hour 48 minutes ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 2 hours ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan